Wellness Apps vs Digital Therapeutics
How a general wellness app differs from a prescription digital therapy, using FDA's own categories, two cleared insomnia products as examples, and what app store claims leave out.
Content last updated . This page has not been medically reviewed.
"Digital therapeutic" is a common industry phrase, not a separate legal category in the FDA pages we read. The FDA sorts software by what it is intended to do. The phrase does appear inside FDA clearance records for specific products, which is where this page takes its examples. [2]
How the FDA sorts health software (United States)
| Type of software | What it says it does | FDA position as read |
|---|---|---|
| General wellness | Supports general health, for example weight management, fitness, relaxation or stress management, or sleep management, with no reference to a disease | Falls under the general wellness policy (guidance issued January 6, 2026) [3] |
| Disease self-management tool | Helps a person self-manage a condition without giving specific treatment suggestions | Can be a device, but the FDA says it will exercise enforcement discretion, meaning it does not expect premarket review [4] |
| Device software function | Diagnoses, treats or guides treatment | Regulated as a medical device; the FDA focuses on software that could harm a patient if it fails [4] |
The line is drawn by the claim. The FDA's wellness guidance gives "a product helps treat an anxiety disorder" as an example of a claim that is not a general wellness claim. [3] In other words, a sleep tracker that says it helps you track sleep trends is a wellness claim, while an app that says it treats a disease or condition is making a different kind of claim, which the wellness policy does not cover. [3]
What a prescription digital therapy looks like: two insomnia examples
Two products show what the cleared end looks like. In each case the facts below are specific to that product and that indication.- Somryst (Pear Therapeutics), FDA 510(k) K191716, decision date March 23, 2020. Its cleared indication is cognitive behavioral therapy for insomnia (CBT-I) in patients 22 years of age and older with chronic insomnia. It is prescription-only. [2][5]
- Sleepio (Big Health), FDA 510(k) K233577, letter dated August 5, 2024. Cleared for chronic insomnia or insomnia disorder as an adjunct to usual care in patients aged 18 and older, and it is a prescription device. [6]
Both were cleared under the FDA's rule for a "computerized behavioral therapy device for psychiatric disorders," which describes a prescription device that gives a computerized version of condition-specific behavioral therapy as an adjunct to clinician-supervised outpatient treatment. [7] That rule requires clinical data showing a validated model of behavioral therapy and validation of how the device carries it out. [7]
The Sleepio summary describes a randomized trial of 336 adults comparing the program with online sleep hygiene education, and says no adverse or serious adverse events were reported by participants. [6] The summary also states that Sleepio was found substantially equivalent to Somryst. [6] See Digital CBT for Insomnia: Evidence for the wider research.
What a clearance does and does not tell you
- It names one product and one indication. Somryst's indication is chronic insomnia in people 22 and older, so it says nothing about other sleep apps or other conditions. [2]
- It is not a blanket stamp on a company's marketing. For how "FDA registered" differs from "FDA approved," see Claim Check: "FDA Registered" vs Product Approval.
- It does not make "digital therapeutic" a safe label for any app that uses the phrase. Check the FDA's databases for the exact product name and indication.
What the wellness end of the market offers
A 2019 study coded the app store descriptions of 73 top-ranking consumer mental health apps. Of these, 64% claimed to diagnose a condition or to improve symptoms, mood or self-management. Scientific language was the most common support (44%), and only one app cited published literature. [8] That study looked at one slice of the market at one moment, and listings change, so treat it as a caution about marketing, not a verdict on every app.An FDA advisory committee summary from November 2025 says most commercially available digital mental health products are consumer wellness apps that FDA does not review or authorize, and that this has been a source of confusion for users. [1] It reported that FDA had authorized fewer than twenty digital mental health medical devices that use non-AI technologies. [1]
Questions to ask about any health app
| Question | Why it matters |
|---|---|
| What condition does the app claim to treat, if any? | A condition claim moves it out of the general wellness policy [3] |
| Is there an FDA clearance for this exact product, and for what indication and age group? | Clearances are product-specific [2] |
| Is it prescription-only? | Cleared behavioral therapy devices in these examples are prescription devices [6] |
| Is there a trial of this product, not just of the therapy it copies? | See Product-Specific Trials for Digital Health |
| Where does your data go? | See Digital Health Data Privacy |
Where this fits
Consumer tracking and wearables are covered in the Biohacking library: Wearables and Health Trackers. For the regulatory picture across product types, see Regulatory Status of Digital Health Products. A shorter side-by-side is at Digital Therapeutics vs Wellness Apps. If you live with a mental health condition, an app should not replace care from a clinician; talk with your prescriber before changing any medicine. In the US, the 988 Suicide & Crisis Lifeline is there if you are in crisis, and 911 is for emergencies.
Frequently asked questions
Is a prescription digital therapy the same as a medicine?
No. In the examples above, the FDA cleared the products as medical devices, not as drugs. The cleared indication and the requirement for a prescription are product-specific. [2][6]
Can a wellness app say it treats insomnia or anxiety?
Under the FDA's general wellness policy, a claim to help treat an anxiety disorder is not a general wellness claim. [3] Check the FDA's databases for the exact product before relying on a treatment claim.
Does "clinically validated" on an app listing mean it was cleared by the FDA?
No. The phrase is not a regulatory status. In the 2019 study of app store descriptions, scientific language was common but published evidence was rarely cited. [8]
Should I stop or change a medicine because of an app?
No. Talk with your prescriber or pharmacist before changing any medicine. This page is general information and not a recommendation for any product.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
How to read the evidence labels
Labels used on this page: approved medicine or cleared device (we name the regulator, product and indication), promising but limited, marketing claim, and insufficient evidence. A clearance and a trial result are different things, and this page keeps them apart. This covers the United States only; we did not verify other countries' rules for this page. Rules change and this is not legal advice.
References
- U.S. Food and Drug Administration. Executive Summary for the Digital Health Advisory Committee Meeting: Generative AI-Enabled Digital Mental Health Medical Devices, November 6, 2025. Read 2026-10-22.
- U.S. Food and Drug Administration. Somryst 510(k) K191716: clearance letter, indications for use and summary. Read 2026-10-22.
- U.S. Food and Drug Administration. General Wellness: Policy for Low Risk Devices, guidance issued January 6, 2026. Read 2026-10-22.
- U.S. Food and Drug Administration. Device Software Functions Including Mobile Medical Applications. Read 2026-10-22.
- U.S. Food and Drug Administration. 510(k) Premarket Notification database record K191716 (Somryst). Read 2026-10-22.
- U.S. Food and Drug Administration. Sleepio 510(k) K233577: clearance letter and summary. Read 2026-10-22.
- U.S. Code of Federal Regulations. 21 CFR 882.5801 Computerized behavioral therapy device for psychiatric disorders (eCFR). Read 2026-10-22.
- Using science to sell apps: evaluation of mental health app store quality claims. npj Digital Medicine, 2019. Read 2026-10-22.